American Vanguard (AVD) Expected to Release Earnings on Monday

American Vanguard (NYSE:AVD) is expected to be announcing its Q3 2026 resultson Monday, November 9th. Analysts expect American Vanguard to announce earnings of ($0.01) per share and revenue of $130.00 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Monday, November 9, 2026 at 9:00 AM ET.

American Vanguard (NYSE:AVD) last released its earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). The business had revenue of $116.75 million for the quarter, compared to analyst estimates of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

American Vanguard Stock Performance

Shares of AVD stock opened at $1.10 on Monday. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.40 and a current ratio of 2.47. American Vanguard has a fifty-two week low of $1.00 and a fifty-two week high of $5.55. The stock has a 50 day simple moving average of $1.78 and a two-hundred day simple moving average of $2.88. The company has a market cap of $32.45 million, a P/E ratio of -0.58 and a beta of 1.56.

Insider Buying and Selling at American Vanguard

In other American Vanguard news, Director Steven D. Macicek acquired 19,000 shares of the company’s stock in a transaction on Monday, August 17th. The shares were purchased at an average cost of $2.09 per share, with a total value of $39,710.00. Following the completion of the purchase, the director owned 99,711 shares of the company’s stock, valued at approximately $208,395.99. This represents a 23.54% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Keith Rosenbloom sold 556,580 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $2.20, for a total transaction of $1,224,476.00. Following the sale, the director directly owned 15,201 shares of the company’s stock, valued at approximately $33,442.20. The trade was a 97.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 5.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. Wall Street Zen lowered American Vanguard from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

About American Vanguard

American Vanguard Corporation, doing business primarily through its AMVAC subsidiary, develops, manufactures and markets specialty agricultural products. The company’s portfolio includes crop protection products such as insecticides, herbicides, fungicides, nematicides and soil fumigants designed to help growers manage pests, weeds and plant diseases.

In addition to crop protection, American Vanguard serves the professional and consumer markets for turf and ornamental care, golf course management, pest control and public health.